Contrast Enhanced Ultrasound Market Report 2026

Contrast Enhanced Ultrasound Market Overview

• Contrast Enhanced Ultrasound market size has reached to $2.13 billion in 2025 • Expected to grow to $2.84 billion in 2030 at a compound annual growth rate (CAGR) of 5.9% • Growth Driver: The Role of Imaging Technology in Chronic Disease Forecasting • Market Trend: Advancements In Contrast-Enhanced Ultrasound (CEUS) Technology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Contrast Enhanced Ultrasound Market?

Contrast-enhanced ultrasound (CEUS) refers to a medical imaging technique that involves the use of contrast agents or microbubbles to enhance the visibility and clarity of ultrasound images. CEUS can be used to image blood perfusion in organs and measure blood flow rate in the heart and other organs. The main products of contrast enhanced ultrasound are equipment and contrast agents. Equipment refers to the physical tools, machinery, devices, or instruments that perform specific tasks, operations, or functions. Equipment includes ultrasound machines and associated devices that are used to create real-time images with contrast agents. They are based non-targeted and targeted technologies for hospitals, clinics, and other applications.

What Is The Contrast Enhanced Ultrasound Market Growth Forecast?

The contrast enhanced ultrasound market size is expected to see strong growth in the next few years. It will grow to $2.84 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing demand for real-time functional imaging, rising investments in advanced diagnostic ultrasound systems, expansion of ceus applications in oncology, growing focus on non-invasive imaging techniques, increasing approvals of next-generation contrast agents. Major trends in the forecast period include increasing adoption of microbubble-based imaging agents, rising use of ceus in cardiology and oncology, growing integration of advanced ultrasound software, expansion of portable contrast-enhanced ultrasound systems, enhanced focus on real-time perfusion imaging.

Global Contrast Enhanced Ultrasound Market Segmentation

1) By Product: Equipment, Contrast Agent 2) By Technology: Non-targeted, Targeted 3) By Application: Hospitals, Clinics, Other Applications Subsegments: 1) By Equipment: Ultrasound Machines, Portable Ultrasound Devices 2) By Contrast Agent: Gas-filled Contrast Agents, Microbubble Contrast Agents, Lipid-based Contrast Agents

What Is The Driver Of The Contrast Enhanced Ultrasound Market?

The rising prevalence of chronic diseases is expected to propel the growth of the contrast-enhanced ultrasound market going forward. Chronic diseases refer to long-term medical conditions that persist over an extended period and require ongoing medical management and care. Contrast-enhanced ultrasound helps provide real-time, detailed images of various chronic diseases, such as liver cirrhosis or vascular diseases associated with hypertension, contributing to more effective long-term management. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the rising prevalence of chronic diseases will drive the growth of the contrast-enhanced ultrasound market.

Key Players In The Global Contrast Enhanced Ultrasound Market

Major companies operating in the contrast enhanced ultrasound market are General Electric Company, Bayer AG, Siemens Healthcare GmbH, Koninklijke Philips N.V., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Canon Medical Systems, Lantheus Medical Imaging Inc., Guerbet, Bracco Diagnostic Inc., Esaote S.p.A., Trivitron Healthcare Pvt. Ltd., BK Medical Holding Company Inc., Hitachi Healthcare, Chison Medical Technology Co. Ltd., SANOCHEMIA Pharmazeutika GmbH, SuperSonic Imagine SA, FUJIFILM Visualsonics Inc., Samsung Healthcare, Alpinion Medical Systems, Acusphere Inc., Solstice Pharmaceuticals B.V.

Global Contrast Enhanced Ultrasound Market Trends and Insights

Major companies operating in the contrast-enhanced ultrasound market are developing advanced technologies, such as super-resolution contrast-enhanced ultrasound (CEUS) technology, to improve the spatial resolution of CEUS images. The integration of advanced technologies in contrast-enhanced ultrasound enhances diagnostic capabilities, enabling healthcare professionals to obtain more detailed and accurate information about the anatomy, function, and perfusion of tissues and organs. For instance, in September 2023, Philips, a Netherlands-based company that develops and manufactures medical systems and consumer electronics products, launched Philips Microvascular Imaging Super Resolution Contrast-Enhanced Ultrasound (CEUS), a super-resolution CEUS technology that uses advanced signal processing algorithms to improve the spatial resolution of CEUS images. It helps to provide high-resolution images of blood vessels and other structures to diagnose and treat a variety of diseases, including cancer, liver disease, and vascular diseases.

What Are Latest Mergers And Acquisitions In The Contrast Enhanced Ultrasound Market?

In July 2024, GE HealthCare Technologies Inc., US-based medical technology company, acquired Intelligent Ultrasound Group PLC for an undisclosed amount. Through this acquisition, GE HealthCare Technologies Inc. aims to integrate Intelligent Ultrasound's advanced solutions into GE HealthCare's ultrasound portfolio, enhancing the efficiency and intelligence of their ultrasound offerings. The incorporation of these AI-driven technologies is expected to significantly improve the accuracy and usability of ultrasound systems, addressing the growing demand for smarter imaging solutions in the healthcare industry. Intelligent Ultrasound Group PLC is a UK-based healthcare technology firm specializing in innovative ultrasound systems, particularly in contrast-enhanced ultrasound applications.

Regional Outlook

North America was the largest region in the contrast-enhanced ultrasound market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Contrast Enhanced Ultrasound Market?

The contrast-enhanced ultrasound market consists of revenues earned by entities by providing services such as diagnostic imaging services, treatment planning services, and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The contrast-enhanced ultrasound market also includes sales of transducers, injectors, guidance tools, and imaging software that are used in providing comprehensive contrast-enhanced ultrasound. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.